Neurosurgical Review

, Volume 37, Issue 2, pp 179–192 | Cite as

Current management of choroid plexus carcinomas

  • Matthew Z. Sun
  • Michael C. Oh
  • Michael E. Ivan
  • Gurvinder Kaur
  • Michael Safaee
  • Joseph M. Kim
  • Joanna J. Phillips
  • Kurtis I. Auguste
  • Andrew T. Parsa


Choroid plexus carcinoma (CPC) is a World Health Organization (WHO) grade III brain tumor with a poor prognosis that occurs mainly in children. Gross total resection of CPC is highly recommended and is associated with improved overall survival, although it is often associated with increased morbidity. The use of adjuvant therapies has yet to be standardized, although evidence suggests that for patients with incompletely resected CPCs, a combination of chemotherapy and radiation therapy may be beneficial. The use of radiation therapy for younger children (<3 years old) with CPC, however, is not recommended, due to the potential negative neurological sequelae associated with radiation to the developing brain. Given that the majority of CPC patients are young children, questions regarding optimal radiation dose, chemotherapy agents, and how to combine these two adjuvant treatment modalities to achieve the best outcomes remain unanswered. In this paper we summarize the current management of CPC in the literature. Further studies are needed to standardize the treatment paradigm for this malignant brain tumor.


Choroid plexus carcinoma Radiation therapy Chemotherapy Surgery 




Conflict of interest

The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.


M.Z. Sun is a Howard Hughes Medical Institute medical research fellow. M. Safaee was supported by a grant from the Doris Duke Charitable Foundation. Dr. Oh received a National Research Service Award from the National Institutes of Health (F32NS073326-01). Dr. Ivan is funded by the National Research Education Foundation through the American Association of Neurological Surgeons. Dr. Parsa is partially funded by the Reza and Georgianna Khatib Endowed Chair in Skull Base Tumor Surgery.


  1. 1.
    Ahn SS, Cho YD (2007) Spinal drop metastasis from a posterior fossa choroid plexus papilloma. J Kor Neurosurg Soc 42(6):475–477. doi: 10.3340/jkns.2007.42.6.475 CrossRefGoogle Scholar
  2. 2.
    Al-Anazi A, Shannon P, Guha A (2000) Solitary metastasis to the choroid plexus. Case illustration. J Neurosurg 92(3):506PubMedCrossRefGoogle Scholar
  3. 3.
    Allen J, Wisoff J, Helson L, Pearce J, Arenson E (1992) Choroid plexus carcinoma—responses to chemotherapy alone in newly diagnosed young children. J Neurooncol 12(1):69–74PubMedGoogle Scholar
  4. 4.
    Araki K, Aori T, Takahashi JA, Nozaki K, Nagata I, Kikuchi H, Yokoyama M, Hattori H, Akiyama Y, Kubota Y, Yokomizo H (1997) A case report of choroid plexus carcinoma. No Shinkei Geka 25(9):853–857PubMedGoogle Scholar
  5. 5.
    Ausman JI, Shrontz C, Chason J, Knighton RS, Pak H, Patel S (1984) Aggressive choroid plexus papilloma. Surg Neurol 22(5):472–476PubMedCrossRefGoogle Scholar
  6. 6.
    Berger C, Thiesse P, Lellouch-Tubiana A, Kalifa C, Pierre-Kahn A, Bouffet E (1998) Choroid plexus carcinomas in childhood: clinical features and prognostic factors. Neurosurgery 42(3):470–475PubMedCrossRefGoogle Scholar
  7. 7.
    Berrak SG, Liu DD, Wrede B, Wolff JE (2011) Which therapy works better in choroid plexus carcinomas? J Neurooncol 103(1):155–162. doi: 10.1007/s11060-010-0372-9 PubMedCrossRefGoogle Scholar
  8. 8.
    Boyd MC, Steinbok P (1987) Choroid plexus tumors: problems in diagnosis and management. J Neurosurg 66(6):800–805. doi: 10.3171/jns.1987.66.6.0800 PubMedCrossRefGoogle Scholar
  9. 9.
    Carlotti CG Jr, Salhia B, Weitzman S, Greenberg M, Dirks PB, Mason W, Becker LE, Rutka JT (2002) Evaluation of proliferative index and cell cycle protein expression in choroid plexus tumors in children. Acta Neuropathol 103(1):1–10PubMedCrossRefGoogle Scholar
  10. 10.
    Carter AB, Price DL Jr, Tucci KA, Lewis GK, Mewborne J, Singh HK (2001) Choroid plexus carcinoma presenting as an intraparenchymal mass. J Neurosurg 95(6):1040–1044. doi: 10.3171/jns.2001.95.6.1040 PubMedCrossRefGoogle Scholar
  11. 11.
    Chow E, Reardon DA, Shah AB, Jenkins JJ, Langston J, Heideman RL, Sanford RA, Kun LE, Merchant TE (1999) Pediatric choroid plexus neoplasms. Int J Radiat Oncol Biol Phys 44(2):249–254PubMedCrossRefGoogle Scholar
  12. 12.
    Coates TL, Hinshaw DB Jr, Peckman N, Thompson JR, Hasso AN, Holshouser BA, Knierim DS (1989) Pediatric choroid plexus neoplasms: MR, CT, and pathologic correlation. Radiology 173(1):81–88PubMedGoogle Scholar
  13. 13.
    Custodio G, Taques GR, Figueiredo BC, Gugelmin ES, Oliveira Figueiredo MM, Watanabe F, Pontarolo R, Lalli E, Torres LF (2011) Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil. PLoS One 6(3):e18015. doi: 10.1371/journal.pone.0018015 PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Donovan DJ, Prauner RD (2005) Shunt-related abdominal metastases in a child with choroid plexus carcinoma: case report. Neurosurgery 56 (2):E412; discussion E412Google Scholar
  15. 15.
    Due-Tonnessen B, Helseth E, Skullerud K, Lundar T (2001) Choroid plexus tumors in children and young adults: report of 16 consecutive cases. Childs Nerv Syst 17(4–5):252–256PubMedCrossRefGoogle Scholar
  16. 16.
    Duffner PK, Cohen ME, Thomas PR, Lansky SB (1985) The long-term effects of cranial irradiation on the central nervous system. Cancer 56(7 Suppl):1841–1846PubMedCrossRefGoogle Scholar
  17. 17.
    Duffner PK, Kun LE, Burger PC, Horowitz ME, Cohen ME, Sanford RA, Krischer JP, Mulhern RK, James HE, Rekate HL et al (1995) Postoperative chemotherapy and delayed radiation in infants and very young children with choroid plexus carcinomas. The Pediatric Oncology Group. Pediatr Neurosurg 22(4):189–196PubMedCrossRefGoogle Scholar
  18. 18.
    Ellenbogen RG, Donovan DJ (2001) Choroid Plexus Tumors. In: Keating RF, Goodrich JT, Packer RJ (eds) Tumors of the pediatric central nervous system. Thieme, New York, pp 339–350Google Scholar
  19. 19.
    Ellenbogen RG, Winston KR, Kupsky WJ (1989) Tumors of the choroid plexus in children. Neurosurgery 25(3):327–335PubMedCrossRefGoogle Scholar
  20. 20.
    Erkutlu I, Buyukhatipoglu H, Alptekin M, Berkyurek E, Tutar E, Gok A (2009) Spinal drop metastases from a papillary meningioma: a case report and review of the literature: utility of CSF sampling. Med Oncol 26(2):242–246. doi: 10.1007/s12032-008-9101-z PubMedCrossRefGoogle Scholar
  21. 21.
    Geerts Y, Gabreëls F, Lippens R, Merx H, Wesseling P (1996) Choroid plexus carcinoma: a report of two cases and review of the literature. Neuropediatrics 27(3):143–148. doi: 10.1055/s-2007-973765 PubMedCrossRefGoogle Scholar
  22. 22.
    Gopal P, Parker JR, Debski R, Joseph C Parker J (2008) Choroid plexus carcinomaGoogle Scholar
  23. 23.
    Greenberg ML (1999) Chemotherapy of choroid plexus carcinoma. Childs Nerv Syst 15(10):571–577PubMedCrossRefGoogle Scholar
  24. 24.
    Griffin BR, Stewart GR, Berger MS, Geyer JR, O'Dell M, Rostad S (1988) Choroid plexus carcinoma of the fourth ventricle. Report of a case in an infant. Pediatr Neurosci 14(3):134–139PubMedCrossRefGoogle Scholar
  25. 25.
    Hasselblatt M, Bohm C, Tatenhorst L, Dinh V, Newrzella D, Keyvani K, Jeibmann A, Buerger H, Rickert CH, Paulus W (2006) Identification of novel diagnostic markers for choroid plexus tumors: a microarray-based approach. Am J Surg Pathol 30(1):66–74PubMedCrossRefGoogle Scholar
  26. 26.
    Hasselblatt M, Muhlisch J, Wrede B, Kallinger B, Jeibmann A, Peters O, Kutluk T, Wolff JE, Paulus W, Fruhwald MC (2009) Aberrant MGMT (O6-methylguanine-DNA methyltransferase) promoter methylation in choroid plexus tumors. J Neurooncol 91(2):151–155. doi: 10.1007/s11060-008-9694-2 PubMedCrossRefGoogle Scholar
  27. 27.
    Hayakawa I, Fujiwara K, Tsuchida T, Aoki M (1979) Choroid plexus carcinoma with metastasis to bone (author's transl). No Shinkei Geka 7(8):815–818PubMedGoogle Scholar
  28. 28.
    Hegi ME, Diserens AC, Godard S, Dietrich PY, Regli L, Ostermann S, Otten P, Van Melle G, de Tribolet N, Stupp R (2004) Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 10(6):1871–1874PubMedCrossRefGoogle Scholar
  29. 29.
    Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10):997–1003. doi: 10.1056/NEJMoa043331 PubMedCrossRefGoogle Scholar
  30. 30.
    Janisch W, Staneczek W (1989) Primary tumors of the choroid plexus. Frequency, localization and age. Zentralbl Allg Pathol 135(3):235–240PubMedGoogle Scholar
  31. 31.
    Jeibmann A, Hasselblatt M, Gerss J, Wrede B, Egensperger R, Beschorner R, Hans VH, Rickert CH, Wolff JE, Paulus W (2006) Prognostic implications of atypical histologic features in choroid plexus papilloma. J Neuropathol Exp Neurol 65(11):1069–1073. doi: 10.1097/01.jnen.0000240464.26005.90 PubMedCrossRefGoogle Scholar
  32. 32.
    Jeibmann A, Wrede B, Peters O, Wolff JE, Paulus W, Hasselblatt M (2007) Malignant progression in choroid plexus papillomas. J Neurosurg 107(3 Suppl):199–202. doi: 10.3171/PED-07/09/199 PubMedGoogle Scholar
  33. 33.
    Judkins AR, Burger PC, Hamilton RL, Kleinschmidt-DeMasters B, Perry A, Pomeroy SL, Rosenblum MK, Yachnis AT, Zhou H, Rorke LB, Biegel JA (2005) INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. J Neuropathol Exp Neurol 64(5):391–397PubMedGoogle Scholar
  34. 34.
    Kang HS, Wang KC, Kim YM, Kim IO, Kim SK, Chi JG, Cho BK (1997) Choroid plexus carcinoma in an infant. J Kor Med Sci 12(2):162–167Google Scholar
  35. 35.
    Kato T, Fujita M, Sawamura Y, Tada M, Abe H, Nagashima K, Nakamura N (1996) Clinicopathological study of choroid plexus tumors: immunohistochemical features and evaluation of proliferative potential by PCNA and Ki-67 immunostaining. Noshuyo Byori 13(2):99–105PubMedGoogle Scholar
  36. 36.
    Kimura M, Takayasu M, Suzuki Y, Negoro M, Nagasaka T, Nakashima N, Sugita K (1992) Primary choroid plexus papilloma located in the suprasellar region: case report. Neurosurgery 31(3):563–566PubMedCrossRefGoogle Scholar
  37. 37.
    Kleinberg L, Wallner K, Malkin MG (1993) Good performance status of long-term disease-free survivors of intracranial gliomas. Int J Radiat Oncol Biol Phys 26(1):129–133PubMedCrossRefGoogle Scholar
  38. 38.
    Kohno M, Matsutani M, Sasaki T, Takakura K (1996) Solitary metastasis to the choroid plexus of the lateral ventricle. Report of three cases and a review of the literature. J Neurooncol 27(1):47–52PubMedCrossRefGoogle Scholar
  39. 39.
    Krutilkova V, Trkova M, Fleitz J, Gregor V, Novotna K, Krepelova A, Sumerauer D, Kodet R, Siruckova S, Plevova P, Bendova S, Hedvicakova P, Foreman NK, Sedlacek Z (2005) Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations. Eur J Cancer 41(11):1597–1603. doi: 10.1016/j.ejca.2005.01.026 PubMedCrossRefGoogle Scholar
  40. 40.
    Kumabe T, Tominaga T, Kondo T, Yoshimoto T, Kayama T (1996) Intraoperative radiation therapy and chemotherapy for huge choroid plexus carcinoma in an infant—case report. Neurol Med Chir (Tokyo) 36(3):179–184CrossRefGoogle Scholar
  41. 41.
    Lafay-Cousin L, Mabbott DJ, Halliday W, Taylor MD, Tabori U, Kamaly-Asl ID, Kulkarni AV, Bartels U, Greenberg M, Bouffet E (2010) Use of ifosfamide, carboplatin, and etoposide chemotherapy in choroid plexus carcinoma. J Neurosurg Pediatr 5(6):615–621. doi: 10.3171/2010.3.PEDS09354 PubMedCrossRefGoogle Scholar
  42. 42.
    Lavra L, Ulivieri A, Rinaldo C, Dominici R, Volante M, Luciani E, Bartolazzi A, Frasca F, Soddu S, Sciacchitano S (2009) Gal-3 is stimulated by gain-of-function p53 mutations and modulates chemoresistance in anaplastic thyroid carcinomas. J Pathol 218(1):66–75. doi: 10.1002/path.2510 PubMedCrossRefGoogle Scholar
  43. 43.
    Levy ML, Goldfarb A, Hyder DJ, Gonzales-Gomez I, Nelson M, Gilles FH, McComb JG (2001) Choroid plexus tumors in children: significance of stromal invasion. Neurosurgery 48(2):303–309PubMedGoogle Scholar
  44. 44.
    Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) WHO classification of tumours of the central nervous system. International Agency for Research on Cancer, LyonGoogle Scholar
  45. 45.
    Lozier AP, Arbaje YM, Scheithauer BW (2009) Supratentorial, extraventricular choroid plexus carcinoma in an adult: case report. Neurosurgery 65(4):E816–E817. doi: 10.1227/01.NEU.0000348291.48810.C2 PubMedCrossRefGoogle Scholar
  46. 46.
    Lv SQ, Song YC, Xu JP, Shu HF, Zhou Z, An N, Huang QL, Yang H (2012) A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma. Med Sci Monit 18(5):CS37–CS41PubMedCentralPubMedGoogle Scholar
  47. 47.
    Matson D (1969) Tumors of the choroid plexus. In: Matson D (ed) Neurosurgery of infancy and childhood. Charles C Thomas, Springfield, pp 581–595Google Scholar
  48. 48.
    McCall T, Binning M, Blumenthal DT, Jensen RL (2006) Variations of disseminated choroid plexus papilloma: 2 case reports and a review of the literature. Surg Neurol 66(1):62–67. doi: 10.1016/j.surneu.2005.09.023, discussion 67–68PubMedCrossRefGoogle Scholar
  49. 49.
    McDonald JV (1969) Persistent hydrocephalus following the removal of papillomas of the choroid plexus of the lateral ventricles. Report of two cases. J Neurosurg 30(6):736–740. doi: 10.3171/jns.1969.30.6.0736 PubMedCrossRefGoogle Scholar
  50. 50.
    Menon G, Nair SN, Baldawa SS, Rao RB, Krishnakumar KP, Gopalakrishnan CV (2010) Choroid plexus tumors: an institutional series of 25 patients. Neurology India 58(3):429–435. doi: 10.4103/0028-3886.66455 PubMedCrossRefGoogle Scholar
  51. 51.
    Meyers SP, Khademian ZP, Chuang SH, Pollack IF, Korones DN, Zimmerman RA (2004) Choroid plexus carcinomas in children: MRI features and patient outcomes. Neuroradiology 46(9):770–780. doi: 10.1007/s00234-004-1238-7 PubMedCrossRefGoogle Scholar
  52. 52.
    Misaki K, Nakada M, Mohri M, Hayashi Y, Hamada J (2011) MGMT promoter methylation and temozolomide response in choroid plexus carcinoma. Brain Tumor Pathol 28(3):259–263. doi: 10.1007/s10014-011-0033-5 PubMedCrossRefGoogle Scholar
  53. 53.
    Mishra A, Srivastava C, Singh SK, Chandra A, Ojha BK (2012) Choroid plexus carcinoma: case report and review of literature. J Pediatr Neurosci 7(1):71–73. doi: 10.4103/1817-1745.97633 PubMedCentralPubMedCrossRefGoogle Scholar
  54. 54.
    Ogiwara H, Dipatri AJ, Alden TD, Bowman RM, Tomita T (2011) Choroid plexus tumors in pediatric patients. Br J Neurosurg. doi: 10.3109/02688697.2011.601820 PubMedGoogle Scholar
  55. 55.
    Packer RJ, Perilongo G, Johnson D, Sutton LN, Vezina G, Zimmerman RA, Ryan J, Reaman G, Schut L (1992) Choroid plexus carcinoma of childhood. Cancer 69(2):580–585PubMedCrossRefGoogle Scholar
  56. 56.
    Pencalet P, Sainte-Rose C, Lellouch-Tubiana A, Kalifa C, Brunelle F, Sgouros S, Meyer P, Cinalli G, Zerah M, Pierre-Kahn A, Renier D (1998) Papillomas and carcinomas of the choroid plexus in children. J Neurosurg 88(3):521–528. doi: 10.3171/jns.1998.88.3.0521 PubMedCrossRefGoogle Scholar
  57. 57.
    Pierga JY, Kalifa C, Terrier-Lacombe MJ, Habrand JL, Lemerle J (1993) Carcinoma of the choroid plexus: a pediatric experience. Med Pediatr Oncol 21(7):480–487PubMedCrossRefGoogle Scholar
  58. 58.
    Rickert CH, Paulus W (2001) Tumors of the choroid plexus. Microsc Res Tech 52(1):104–111. doi: 10.1002/1097-0029(20010101)52:1<104::AID-JEMT12>3.0.CO;2-3 PubMedCrossRefGoogle Scholar
  59. 59.
    Schijman E, Monges J, Raimondi AJ, Tomita T (1990) Choroid plexus papillomas of the III ventricle in childhood. Their diagnosis and surgical management. Childs Nerv Syst 6(6):331–334PubMedCrossRefGoogle Scholar
  60. 60.
    Schittenhelm J, Nagel C, Meyermann R, Beschorner R (2011) Atypical teratoid/rhabdoid tumors may show morphological and immunohistochemical features seen in choroid plexus tumors. Neuropathology 31(5):461–467. doi: 10.1111/j.1440-1789.2010.01189.x PubMedCrossRefGoogle Scholar
  61. 61.
    Seidinger AL, Mastellaro MJ, Paschoal Fortes F, Godoy Assumpcao J, Aparecida Cardinalli I, Aparecida Ganazza M, Correa Ribeiro R, Brandalise SR, Dos Santos Aguiar S, Yunes JA (2011) Association of the highly prevalent TP53 R337H mutation with pediatric choroid plexus carcinoma and osteosarcoma in southeast Brazil. Cancer 117(10):2228–2235. doi: 10.1002/cncr.25826 PubMedCrossRefGoogle Scholar
  62. 62.
    St Clair SK, Humphreys RP, Pillay PK, Hoffman HJ, Blaser SI, Becker LE (1991) Current management of choroid plexus carcinoma in children. Pediatr Neurosurg 17(5):225–233PubMedCrossRefGoogle Scholar
  63. 63.
    Strojan P, Popovic M, Surlan K, Jereb B (2004) Choroid plexus tumors: a review of 28-year experience. Neoplasma 51(4):306–312PubMedGoogle Scholar
  64. 64.
    Tabori U, Shlien A, Baskin B, Levitt S, Ray P, Alon N, Hawkins C, Bouffet E, Pienkowska M, Lafay-Cousin L, Gozali A, Zhukova N, Shane L, Gonzalez I, Finlay J, Malkin D (2010) TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. J Clin Oncol 28(12):1995–2001. doi: 10.1200/JCO.2009.26.8169 PubMedCrossRefGoogle Scholar
  65. 65.
    Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3(3):159–168. doi: 10.1016/S1474-4422(04)00680-5 PubMedCrossRefGoogle Scholar
  66. 66.
    Valladares JB, Perry RH, Kalbag RM (1980) Malignant choroid plexus papilloma with extraneural metastasis. Case report. J Neurosurg 52(2):251–255. doi: 10.3171/jns.1980.52.2.0251 PubMedCrossRefGoogle Scholar
  67. 67.
    Vinchon M, Dhellemmes P (2000) Third ventricle tumors in children. Neurochirurgie 46(3):323–334PubMedGoogle Scholar
  68. 68.
    Wilhelm M, Hirsch W, Merkenschlager A, Stepan H, Geyer C, Kiess W (2012) A rare case of congenital choroid plexus carcinoma. Pediatr Hematol Oncol 29(7):643–646. doi: 10.3109/08880018.2012.710298 PubMedGoogle Scholar
  69. 69.
    Wolff JE, Sajedi M, Brant R, Coppes MJ, Egeler RM (2002) Choroid plexus tumours. Br J Cancer 87(10):1086–1091. doi: 10.1038/sj.bjc.6600609 PubMedCentralPubMedCrossRefGoogle Scholar
  70. 70.
    Wolff JE, Sajedi M, Coppes MJ, Anderson RA, Egeler RM (1999) Radiation therapy and survival in choroid plexus carcinoma. Lancet 353(9170):2126PubMedCrossRefGoogle Scholar
  71. 71.
    Wrede B, Hasselblatt M, Peters O, Thall PF, Kutluk T, Moghrabi A, Mahajan A, Rutkowski S, Diez B, Wang X, Pietsch T, Kortmann RD, Paulus W, Jeibmann A, Wolff JE (2009) Atypical choroid plexus papilloma: clinical experience in the CPT-SIOP-2000 study. J Neurooncol 95(3):383–392. doi: 10.1007/s11060-009-9936-y PubMedCrossRefGoogle Scholar
  72. 72.
    Wrede B, Liu P, Ater J, Wolff JE (2005) Second surgery and the prognosis of choroid plexus carcinoma—results of a meta-analysis of individual cases. Anticancer Res 25(6C):4429–4433PubMedGoogle Scholar
  73. 73.
    Wrede B, Liu P, Wolff JE (2007) Chemotherapy improves the survival of patients with choroid plexus carcinoma: a meta-analysis of individual cases with choroid plexus tumors. J Neurooncol 85(3):345–351. doi: 10.1007/s11060-007-9428-x PubMedCrossRefGoogle Scholar
  74. 74.
    Wyatt SS, Price RA, Holthouse D, Elsaleh H (2001) Choroid plexus carcinoma in an adult. Australas Radiol 45(3):369–371PubMedCrossRefGoogle Scholar
  75. 75.
    Yoshida K, Sato K, Kitai R, Hashimoto N, Kubota T, Kikuta KI (2012) Coincident choroid plexus carcinoma and adrenocortical tumor in an infant. Brain Tumor Pathol. doi: 10.1007/s10014-012-0112-2 PubMedCentralGoogle Scholar
  76. 76.
    Zakrzewska M, Wojcik I, Zakrzewski K, Polis L, Grajkowska W, Roszkowski M, Augelli BJ, Liberski PP, Rieske P (2005) Mutational analysis of hSNF5/INI1 and TP53 genes in choroid plexus carcinomas. Cancer Genet Cytogenet 156(2):179–182. doi: 10.1016/j.cancergencyto.2004.05.002 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Matthew Z. Sun
    • 1
  • Michael C. Oh
    • 1
  • Michael E. Ivan
    • 1
  • Gurvinder Kaur
    • 1
  • Michael Safaee
    • 1
  • Joseph M. Kim
    • 1
  • Joanna J. Phillips
    • 1
    • 2
  • Kurtis I. Auguste
    • 1
  • Andrew T. Parsa
    • 3
  1. 1.Department of Neurological SurgeryUniversity of California San FranciscoSan FranciscoUSA
  2. 2.Department of PathologyUniversity of California San FranciscoSan FranciscoUSA
  3. 3.Department of Neurological Surgery, Northwestern UniversityFeinberg School of MedicineChicagoUSA

Personalised recommendations